SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,502,232 | +152.2% | 272,213 | +178.0% | 0.01% | +175.0% |
| Q2 2023 | $12,887,442 | +76.2% | 97,914 | +76.9% | 0.00% | +33.3% |
| Q4 2022 | $7,313,263 | +8.2% | 55,349 | -7.9% | 0.00% | 0.0% |
| Q3 2022 | $6,759,000 | -17.1% | 60,104 | -44.1% | 0.00% | -25.0% |
| Q2 2022 | $8,153,000 | -78.4% | 107,596 | -77.6% | 0.00% | -77.8% |
| Q1 2022 | $37,832,000 | +1922.0% | 481,366 | +2237.0% | 0.02% | +1700.0% |
| Q4 2021 | $1,871,000 | -92.7% | 20,598 | -92.7% | 0.00% | -91.7% |
| Q3 2021 | $25,597,000 | +6380.3% | 282,309 | +5642.7% | 0.01% | – |
| Q2 2021 | $395,000 | +42.1% | 4,916 | +26.9% | 0.00% | – |
| Q1 2021 | $278,000 | -96.9% | 3,875 | -96.1% | 0.00% | -100.0% |
| Q4 2020 | $8,841,000 | -44.6% | 98,485 | -13.9% | 0.01% | -53.8% |
| Q3 2020 | $15,964,000 | +5.0% | 114,435 | +28.0% | 0.01% | -7.1% |
| Q2 2020 | $15,199,000 | +3827.4% | 89,435 | +2119.2% | 0.01% | – |
| Q1 2020 | $387,000 | -89.5% | 4,030 | -85.9% | 0.00% | -100.0% |
| Q4 2019 | $3,678,000 | +70.8% | 28,499 | -0.3% | 0.00% | +50.0% |
| Q3 2019 | $2,153,000 | -75.9% | 28,575 | -51.4% | 0.00% | -71.4% |
| Q2 2019 | $8,937,000 | +9.3% | 58,814 | -14.2% | 0.01% | 0.0% |
| Q1 2019 | $8,174,000 | -62.8% | 68,581 | -65.9% | 0.01% | -66.7% |
| Q4 2018 | $21,950,000 | +36.9% | 201,135 | +102.6% | 0.02% | +61.5% |
| Q3 2018 | $16,034,000 | +12.4% | 99,276 | -8.0% | 0.01% | +8.3% |
| Q2 2018 | $14,267,000 | +196.5% | 107,933 | +66.2% | 0.01% | +200.0% |
| Q1 2018 | $4,811,000 | +0.9% | 64,951 | -24.2% | 0.00% | 0.0% |
| Q4 2017 | $4,770,000 | +24.3% | 85,707 | +1.3% | 0.00% | 0.0% |
| Q3 2017 | $3,838,000 | +15.3% | 84,604 | -14.3% | 0.00% | +33.3% |
| Q2 2017 | $3,329,000 | +13.9% | 98,775 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,924,000 | -12.7% | 98,775 | +1.0% | 0.00% | -25.0% |
| Q4 2016 | $3,349,000 | -74.8% | 97,779 | -54.7% | 0.00% | -73.3% |
| Q3 2016 | $13,269,000 | +76.8% | 216,060 | -45.1% | 0.02% | +66.7% |
| Q2 2016 | $7,506,000 | +1637.5% | 393,601 | +1679.2% | 0.01% | – |
| Q1 2016 | $432,000 | +1700.0% | 22,122 | +3272.3% | 0.00% | – |
| Q4 2015 | $24,000 | +50.0% | 656 | +27.4% | 0.00% | – |
| Q3 2015 | $16,000 | 0.0% | 515 | 0.0% | 0.00% | – |
| Q2 2015 | $16,000 | +220.0% | 515 | +24.1% | 0.00% | – |
| Q1 2015 | $5,000 | -16.7% | 415 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | +50.0% | 415 | +150.0% | 0.00% | – |
| Q3 2014 | $4,000 | -87.9% | 166 | -85.0% | 0.00% | – |
| Q2 2014 | $33,000 | +725.0% | 1,106 | +566.3% | 0.00% | – |
| Q1 2014 | $4,000 | -20.0% | 166 | -37.6% | 0.00% | – |
| Q4 2013 | $5,000 | -61.5% | 266 | 0.0% | 0.00% | – |
| Q3 2013 | $13,000 | +116.7% | 266 | +60.2% | 0.00% | – |
| Q2 2013 | $6,000 | – | 166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |